Investing.com - Alpha Tau Medical (NASDAQ: DRTS) reported fourth quarter EPS of $-0.106, $0.01 better than the analyst estimate of $-0.118. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Alpha Tau Medical's stock price closed at $3.030. It is down -2.260% in the last 3 months and down -8.180% in the last 12 months.
Alpha Tau Medical saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Alpha Tau Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Alpha Tau Medical's Financial Health score is "fair performance".
Check out Alpha Tau Medical's recent earnings performance, and Alpha Tau Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar